N-(2-(dimethylamino)-2-oxoethyl)-2-(4-ethoxy-N-methyl-3-(5-methyl-4-oxo-7-propyl-3,4-dihydroimidazo[5,1-f][1,2,4]triazin-2-yl)phenylsulfonamido)-N-methylacetamide manufacturers
- SLX-2101
-
-
2026-06-08
- CAS:906421-01-0
- Min. Order: 1g
- Purity: 99%
- Supply Ability: 5kg
- KD-027
-
- $2500.00
-
2026-05-11
- CAS:906421-01-0
- Purity: 99.55%
- Supply Ability: 10g
|
| | N-(2-(dimethylamino)-2-oxoethyl)-2-(4-ethoxy-N-methyl-3-(5-methyl-4-oxo-7-propyl-3,4-dihydroimidazo[5,1-f][1,2,4]triazin-2-yl)phenylsulfonamido)-N-methylacetamide Basic information |
| Product Name: | N-(2-(dimethylamino)-2-oxoethyl)-2-(4-ethoxy-N-methyl-3-(5-methyl-4-oxo-7-propyl-3,4-dihydroimidazo[5,1-f][1,2,4]triazin-2-yl)phenylsulfonamido)-N-methylacetamide | | Synonyms: | N-(2-(dimethylamino)-2-oxoethyl)-2-(4-ethoxy-N-methyl-3-(5-methyl-4-oxo-7-propyl-3,4-dihydroimidazo[5,1-f][1,2,4]triazin-2-yl)phenylsulfonamido)-N-methylacetamide;Glycinamide, N-[[3-(1,4-dihydro-5-methyl-4-oxo-7-propylimidazo[5,1-f][1,2,4]triazin-2-yl)-4-ethoxyphenyl]sulfonyl]-N-methylglycyl-N,N,N2-trimethyl- (9CI);KD 027;KD027;SLX-2101 KD-027;KD-027;Vardenafil Hydrochloride Impurity 62 | | CAS: | 906421-01-0 | | MF: | C25H35N7O6S | | MW: | 561.65 | | EINECS: | | | Product Categories: | | | Mol File: | 906421-01-0.mol | ![N-(2-(dimethylamino)-2-oxoethyl)-2-(4-ethoxy-N-methyl-3-(5-methyl-4-oxo-7-propyl-3,4-dihydroimidazo[5,1-f][1,2,4]triazin-2-yl)phenylsulfonamido)-N-methylacetamide Structure](CAS/20200611/GIF/906421-01-0.gif) |
| | N-(2-(dimethylamino)-2-oxoethyl)-2-(4-ethoxy-N-methyl-3-(5-methyl-4-oxo-7-propyl-3,4-dihydroimidazo[5,1-f][1,2,4]triazin-2-yl)phenylsulfonamido)-N-methylacetamide Chemical Properties |
| InChIKey | LNDPAVOZUUABGL-UHFFFAOYSA-N | | SMILES | C(N(C(=O)CN(S(C1=CC=C(OCC)C(C2=NC(=O)C3=C(C)N=C(CCC)N3N2)=C1)(=O)=O)C)C)(=O)CN(C)C |
| | N-(2-(dimethylamino)-2-oxoethyl)-2-(4-ethoxy-N-methyl-3-(5-methyl-4-oxo-7-propyl-3,4-dihydroimidazo[5,1-f][1,2,4]triazin-2-yl)phenylsulfonamido)-N-methylacetamide Usage And Synthesis |
| Description | KD-027, also known as SLx-2101, is a PDE5A inhibitor potentially for the treatment of hypertension. |
| | N-(2-(dimethylamino)-2-oxoethyl)-2-(4-ethoxy-N-methyl-3-(5-methyl-4-oxo-7-propyl-3,4-dihydroimidazo[5,1-f][1,2,4]triazin-2-yl)phenylsulfonamido)-N-methylacetamide Preparation Products And Raw materials |
|